Summary
This prediction ended on 05.11.21 with a price of €39.30. The BUY prediction by geldnutzer for Evotec SE saw massive gains of 101.38%. geldnutzer has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evotec SE | -27.262% | -27.262% | -45.815% | -71.200% |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |
Comments by geldnutzer for this prediction
In the thread Evotec AG diskutieren
Buy mit Kursziel 24,0
Kursziel geändert auf 28,0
Kursziel geändert auf 26,0
Kursziel geändert auf 23,0
Kursziel geändert auf 25,0
Kursziel geändert auf 26,0
Kursziel geändert auf 27,0
Kursziel geändert auf 29,0
Kursziel geändert auf 32,0
Kursziel geändert auf 35,0
Kursziel geändert auf 38,0
Kursziel geändert auf 48,0
In the thread Trading Evotec AG
Die von geldnutzer gewählte maximale Laufzeit wurde überschritten